The report "Amorphous Polyethylene Terephthalate Market by Application (Bottles, Films/Sheets, Food Packaging), End-use Industry (Food & Beverages, Pharmaceuticals), Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) - Global Forecast to 2022", The amorphous polyethylene terephthalate (APET) market is estimated to be USD 28.86 Billion in 2017 and is projected to reach USD 40.85 Billion by 2022, at a CAGR of 7.2% during the forecast period from 2017 to 2022. The growth of the amorphous polyethylene terephthalate (APET) market can be attributed to the increasing demand for packaging materials manufactured from amorphous polyethylene terephthalate from the food & beverages industry. Moreover, the increasing purchasing power of consumers, changing lifestyle and food habits of masses, and growing popularity of ready-to-eat food items across the globe are also fueling the growth of the amorphous polyethylene terephthalate (APET) market.
Get PDF brochure of the report: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49340443
Browse 91 Market Data Tables and 35 Figures spread through 145 Pages and in-depth TOC on "Amorphous Polyethylene Terephthalate Market”
In terms of value, the bottles application segment of the amorphous polyethylene terephthalate (APET) market is projected to grow at the highest CAGR during the forecast period.
The bottles application segment of the amorphous polyethylene terephthalate (APET) market is projected to grow at the highest CAGR in terms of value during the forecast period. The increased use of amorphous polyethylene terephthalate (APET) to manufacture bottles can be attributed to high malleability and inert nature of amorphous polyethylene terephthalate. Moreover, the bottles made from amorphous polyethylene terephthalate are lightweight, clear, and tough. The growing use of amorphous polyethylene terephthalate bottles for packaging carbonated soft drinks (CSD), energy drinks, and pharmaceuticals is expected to fuel the growth of the bottles application segment of the amorphous polyethylene terephthalate (APET) market during the forecast period.
In terms of value, the food & beverages end-use industry segment is projected to lead the amorphous polyethylene terephthalate (APET) market from 2017 to 2022.
The food & beverages end-use industry segment is projected to lead the amorphous polyethylene terephthalate (APET) market in terms of value during the forecast period. The increased demand for bottles, containers, and trays, among others, manufactured from amorphous polyethylene terephthalate for packaging food items & beverages, is fueling the growth of the food & beverages end-use industry segment of the market. Changing lifestyle of masses and busy schedules of the working class population across the globe are other factors fueling the consumption of on-the-go food items. This, in turn, is leading to the increased demand for packaging materials made of amorphous polyethylene terephthalate (APET) from the food & beverages industry, thereby fueling the growth of the food & beverages end-use industry segment of the market.
In terms of value, the Asia Pacific amorphous polyethylene terephthalate (APET) market is projected to grow at the highest CAGR during the forecast period.
The Asia Pacific amorphous polyethylene terephthalate (APET) market is expected to grow at the highest CAGR in terms of value during the forecast period. China, India, South Korea, and Australia are the key countries contributing to the demand for amorphous polyethylene terephthalate from the Asia Pacific region. Increasing population and improving economic conditions are the factors expected to drive the growth of the food & beverages industry in the Asia Pacific region, which is further fueling the growth of the amorphous polyethylene terephthalate (APET) in the region.
Some of the key players in the amorphous polyethylene terephthalate (APET) market are Reliance Industries Limited (India), Indorama Ventures Public Company Limited (Thailand), Covestro AG (Germany), Far Eastern New Century Corporation (Taiwan), M&G Chemicals (Luxembourg), Jiangsu Sanfangxiang Group Co., Ltd. (China), JBF Industries Ltd. (India), Nan Ya Plastics Corporation (Taiwan), Polisan Holding (Turkey), DAK Americas (Mexico), INVISTA (US), Sinopec Yizheng Chemical Fibre Company Limited (China), PlastiVerd (Spain), Quadrant AG (Switzerland), Teijin Limited (China), NOVAPET S.A. (Spain), OCTAL (Oman), UAB NEO GROUP (Lithuania), Shahid Tondgooyan Petrochemical Company (Iran), China Resources Packaging Materials Co., Ltd. (China), MPI Polyester Industries (Malaysia), Lotte Chemicals (South Korea), Petro Polymer Shargh (Iran), Equipolymers (Germany), and Dhunseri Petrochem Limited (India).
Early buyers will receive 10% free customization on this report.
Don't miss out on business opportunities in Amorphous Polyethylene Terephthalate (PET) Market.
Speak to Our Analyst and gain crucial industry insights that will help your business grow.
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=49340443
About MarketsandMarkets
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.
Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
[email protected]
The report "Polyurethane Market by Raw Material (MDI, TDI, Polyols), Product (Coatings, Adhesives & Sealants, Flexible & Rigid Foams, Elastomers), End User (Building & Construction, Automotive & Transportation, Bedding & Furniture) - Global Forecast to 2021", The market is driven by the increasing trend in manufacturing light weight & low carbon emitting vehicles and the improved living standards.
Get PDF brochure of the report: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151784541 Browse 114 market data tables and 52 figures spread through 183 pages and in-depth TOC on “Polyurethane Market” Bedding & Furniture: Largest End-User of the Polyurethane MarketIn 2015, the bedding & furniture end-use industry accounted for the largest market share in terms of volume, followed by the building and construction, appliances & white goods and automotive & transportation end-users.
The growing urbanization and the improved living standards of the populations, increasing usage of low cost material in the insulation of buildings, and white goods drives the polyurethane market.
Rigid Foam: The Fastest-growing Product Type Segment of the Polyurethane MarketRigid foam products based on polyurethane systems are estimated to grow at the highest CAGR from 2016 to 2021, in terms of volume.
The excellent properties of rigid foam products such as, easy availability, low cost, recyclability, and easy to use, are driving the demand for this segment.
However, India and Thailand are the fastest-growing markets for polyurethane in the region.The following factors are the main driving forces for the polyurethane market in the Asia-Pacific region:The increasing residential building & construction activities are driving the market in the Asia-Pacific region Growing automotive manufacturing activities are expected to drive the demand for polyurethane in the ASEAN countries Covestro AG (Germany), BASF SE (Germany), The Dow Chemical Company (U.S.), Wanhua Chemical Group Co. Ltd. (China), and Huntsman Corporation (U.S.) are the key players in the polyurethane market.
The Business Research Company published its Propylene Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global propylene market.
The report covers the propylene market’s segments- by end-use industry into automotive, construction, packaging, textile, others.View Complete Report: https://www.thebusinessresearchcompany.com/report/propylene-global-market-reportPropylene Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It covers all the regions, key developed countries and major emerging markets.
The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The propylene market consists of sales of propylene gas and its related services used in various industry verticals such as automotive, construction, and packaging industries.
Asia-Pacific drug safety solutions and pharmacovigilance market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.Drug safety and pharmacovigilance was introduced 170 years ago for detection, assessment, and understanding of the drug action.
The experiment was discovered by Sir James Simpson that chloroform was a powerful anesthetic and for safer use it can be applied in the clinical practices.
The cause of Hannah’s death was studied in order to understand what happened to Hannah as it was difficult to assess the cause of her death and it was assumed that probably lethal arrhythmia or pulmonary aspiration was the main reason leading to such unfavourable situation.
Additionally, in 1961, the U.S. FDA also prohibited false therapeutic indications of drugs.Also, in 1961, European Pharmacovigilance was established after the tragedy of thalidomide which caused an adverse drug reaction named as phocomelia.
In the U.S., ADRs are among the top 10 causes of death, and in the U.K., it was observed that ADRs may cause 5,700 deaths per year.Get More Insights about Asia-Pacific drug safety solutions and pharmacovigilance market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-drug-safety-solutions-and-pharmacovigilance-marketSegmentation: Asia-Pacific Drug Safety Solutions and Pharmacovigilance MarketAsia-Pacific drug safety solutions and pharmacovigilance market is segmented into three notable segments which are type, end user and distribution channel.· On the basis of type, the market is segmented into software and services· On the basis of end user, the market is segmented into hospitals, healthcare providers, pharmaceutical & biotechnology industries, KPOs/BPOs, contract research organizations (CROS) and others· On the basis of distribution channel, the market is segmented into direct sales and retail salesKnow more about this report https://www.databridgemarketresearch.com/reports/asia-pacific-drug-safety-solutions-and-pharmacovigilance-marketAsia-Pacific Drug Safety Solutions and Pharmacovigilance Market By Type (Software, Services), End Users (Biotechnology & Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, Healthcare Providers), Distribution Channel (Direct Sales, Retail Sales), Country (China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific) – Industry Trends and Forecast to 2026Competitive Analysis: Asia-Pacific Drug Safety Solutions and Pharmacovigilance MarketSome of the major players operating in Asia-Pacific drug safety solutions and pharmacovigilance market are Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube, Covance Inc., Accenture, PRA Health Sciences, Inc., Ergomed, IQVIA, Genpact, Cognizant, Parexel International Corporation, ArisGlobal, ICON plc, Oracle, Syneos Health among others.Get Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/asia-pacific-drug-safety-solutions-and-pharmacovigilance-marketRecent DevelopmentsIn November 2019, Oracle launched safety-reporting platform in China with dMed Biopharmaceuticals.
The company will provide pharmacovigilance systems to Chinese drug makers and clinical research organisations (CROs).
